Avai Bio (QB)【AVAI】銘柄情報

Avai Bio Inc (QB) (AVAI) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.18

( -5.26% )

買値

0.17

売値

0.1999

出来高

50,115

0.1751 日の範囲 0.1999

0.16 52 週間の範囲 0.8277

時価総額

24.885M

前日終値

0.19

始値

0.1999

時刻

2000

0.18

最終取引時間

財務取引量

US$ 9,191

VWAP

0.183403

平均取引量 (3 か月)

US$ 137,212

発行済株式数

138,252,252

配当利回り

PER

-25.37

1 株当たり利益 (EPS)

-0.01

歳入

純利益

-1.03M

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Furt... Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology’s usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026. Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania. 詳細を表示

セクター

Technology

業界

Software & It Services

ウェブサイト

avaibio.com

本社

Vilnius, Lithuania

設立

2026

Avai Bio Inc (QB) is listed in the Technology sector of the その他OTC with ticker AVAI. The last closing price for Avai Bio (QB) was US$0.19. Over the last year, Avai Bio (QB) shares have traded in a share price range of US$ 0.16 to US$ 0.8277.

Avai Bio (QB) currently has 138,252,252 shares in issue. The market capitalisation of Avai Bio (QB) is US$24.89 million. Avai Bio (QB) has a price to earnings ratio (PE ratio) of -25.37.

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging...

Form 8-K - Current report

Five Under-the-Radar Stocks With Catalysts Already in Motion — Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security

Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold...

Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells

Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01	-5.26315789474	0.19	0.21	0.1692	140849	0.18223615	CS
4	-0.1499	-45.4380115186	0.3299	0.37	0.16	222688	0.23718589	CS
12	-0.1844	-50.6037321625	0.3644	0.4959	0.16	152726	0.28621591	CS
26	-0.115	-38.9830508475	0.295	0.8	0.16	123501	0.36987986	CS
52	-0.471	-72.3502304147	0.651	0.8277	0.16	124801	0.43305848	CS
156	-1.354	-88.2659713168	1.534	1.98	0.0645	72723	0.5233603	CS
260	-1.354	-88.2659713168	1.534	1.98	0.0645	72723	0.5233603	CS

AVAI - Frequently Asked Questions (FAQ)

What is the current Avai Bio Inc (QB) share price?

The current share price of Avai Bio Inc (QB) is US$ 0.18

How many Avai Bio Inc (QB) shares are in issue?

Avai Bio Inc (QB) has 138,252,252 shares in issue

What is the market cap of Avai Bio Inc (QB)?

The market capitalisation of Avai Bio Inc (QB) is USD 24.89M

What is the 1 year trading range for Avai Bio Inc (QB) share price?

Avai Bio Inc (QB) has traded in the range of US$ 0.16 to US$ 0.8277 during the past year

What is the PE ratio of Avai Bio Inc (QB)?

The price to earnings ratio of Avai Bio Inc (QB) is -25.37

What is the registered address of Avai Bio Inc (QB)?

The registered address for Avai Bio Inc (QB) is Sv. Stepono g. 27D-2, Vilnius

What is the Avai Bio Inc (QB) website address?

The website address for Avai Bio Inc (QB) is avaibio.com

Which industry sector does Avai Bio Inc (QB) operate in?

Avai Bio Inc (QB) operates in the Software & IT Services sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Avai Bio Inc (QB) (AVAI)

Avai Bio Inc (QB) (AVAI) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Avai Bio Inc (QB) について

AVAI 最新ニュース

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

Form 8-K - Current report

Five Under-the-Radar Stocks With Catalysts Already in Motion — Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security

Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells

The Credibility Filter Wall Street Uses to Sort Biotech Winners

Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference

The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step

Anti-Aging Protein Research Takes a Step Forward with Cell Cloning

Advanced Cell-based Therapy Booming the Success for Healthcare Sector

The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

Form 8-K - Current report

Five Under-the-Radar Stocks With Catalysts Already in Motion — Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security

Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells

The Credibility Filter Wall Street Uses to Sort Biotech Winners

Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference

The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step

Anti-Aging Protein Research Takes a Step Forward with Cell Cloning

Advanced Cell-based Therapy Booming the Success for Healthcare Sector

The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed

A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.

Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them

AVAI - Frequently Asked Questions (FAQ)

AVAI 取引

AVAI Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する